Lexaria Bioscience Corp. Annual report pursuant to Section 13 and 15(d)

Segment Information (Details 1) - USD ($)	Aug. 31, 2022	Aug. 31, 2021
Net Balance	$ 315,505	$ 368,213
US [Member]
Net Balance	100,031	69,580
Cost	8,050	101,144
Addition	42,375	(3,904)
Canada [Member]
Net Balance	220,627	298,633
Cost	548,256	548,256
Addition	6,817	0
Leasehold Improvements [Member]
Net Balance	65,296	119,333
Leasehold Improvements [Member] \| US [Member]
Net Balance	0	0
Cost	0	0
Addition	0	0
Leasehold Improvements [Member] \| Canada [Member]
Net Balance	65,296	119,333
Cost	259,981	259,981
Addition	0	0
Furniture Fixtures Equipment [Member]
Net Balance	8,288	14,706
Furniture Fixtures Equipment [Member] \| US [Member]
Net Balance	0	0
Cost	0	3,094
Addition	0	(3,904)
Furniture Fixtures Equipment [Member] \| Canada [Member]
Net Balance	8,288	14,706
Cost	31,126	31,126
Addition	0	0
Lab Equipment [Member]
Net Balance	232,564	221,760
Lab Equipment [Member] \| US [Member]
Net Balance	100,031	69,580
Cost	98,050	98,050
Addition	42,375	0
Lab Equipment [Member] \| Canada [Member]
Net Balance	132,533	152,180
Cost	193,185	193,185
Addition	0	0
Computer Equipment [Member]
Net Balance	9,357	12,414
Computer Equipment [Member] \| US [Member]
Net Balance	0	0
Cost	0	0
Addition	0	0
Computer Equipment [Member] \| Canada [Member]
Net Balance	9,357	12,414
Cost	63,964	63,964
Addition	$ 6,817	$ 0